Format

Send to

Choose Destination
Curr Urol Rep. 2017 Oct 18;18(12):91. doi: 10.1007/s11934-017-0743-2.

Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Early Results.

Author information

1
Department of Urology, Tauranga Hospital, Tauranga, New Zealand.
2
Department of Urology, Tauranga Hospital, Tauranga, New Zealand. peter@urobop.co.nz.
3
Urology Bay of Plenty Ltd, PO Box 893, Tauranga, 3140, New Zealand. peter@urobop.co.nz.

Abstract

Aquablation is a novel technique for the surgical management of bladder outlet obstruction secondary to benign prostatic hyperplasia. Following first-in-man studies, a multicenter trial was conducted with results now out to 1 year. Aquablation resulted in a mean International Prostate Symptom Score improvement of 16 points (p < 0.01) and a mean maximum urinary flow rate increase from 8.7 to 18.3 ml/s (p < 0.01) at 12 months. Due to the precise prostate mapping, aquablation has also demonstrated favorable sexual and urinary outcomes with no new erectile dysfunction, retrograde ejaculation, or urinary incontinence as often experienced with other techniques. These improvements in functional outcomes at 12 months confirm that aquablation is a safe and effective alternative for BPH treatment.

KEYWORDS:

Aquablation; Benign prostatic hyperplasia; Bladder outlet obstruction; Dis-obstruction

PMID:
29046995
DOI:
10.1007/s11934-017-0743-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center